je.st
news
Hansa Medical receives FDA Orphan Drug Designation for IdeS
2015-09-15 06:06:51| Appliances - Topix.net
Hansa Medical today announced that the U.S. Food and Drug Administration has granted orphan drug designation to IdeS for the prevention of antibody mediated organ rejection in solid organ transplant patients. More information about the ODD has been posted on www.fda.com Approximately 30 percent of the patients on the waiting lists for kidney, heart, lung and pancreas, equivalent to approximately 35 000 patients in the US, are sensitized to Human Leukocyte Antigen .
Tags: medical
drug
receives
designation
Category:Consumer Goods and Services
Latest from this category |
All news |
||||||||||||||||||
|
|||||||||||||||||||